Clinical trial
A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In…
NCT00457470 · Pfizer, Industry · Withdrawn
Key facts
| NCT number | NCT00457470 |
|---|---|
| Title | A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME) |
| Official title | A Phase 2, Multi-Stage, Multi-Center Trial Exploring The Safety And Efficacy Of AG-014699 In Subjects With Diffuse Diabetic Macular Edema (DME) Involving The Center Of The Retina |
| Lead sponsor | Pfizer, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | AG-014699 |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| First posted | Apr 6, 2007 |
| Last update posted | May 4, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: